Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Nevada for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Nevada only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Nevada (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Chris Wu (NPI 1265829345)

Field	Value
Entity Type	Individual
Organization	Chris Wu
Address	6980 Smoke Ranch Rd Ste 110
City	Las Vegas
State	NV
ZIP	89128
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	April 16, 2015

Payer Source	Total Paid
Medicare	$1.3M
Medicaid	$0

Key Findings

CHRIS WU operates as a retina specialist whose Medicare revenue is heavily driven by intravitreal drug therapy and retinal imaging. The top revenue codes are J0178 (injection, aflibercept) with $621K revenue (46.2% of Medicare revenue), J3490 (unclassified drugs) with $172.6K (12.9%), and J2777 (injection, faricimab) with $172.3K (12.8%), and these therapy and imaging codes align with a practice centered on anti-VEGF and other intravitreal treatments supported by diagnostic retinal services.

Revenue concentration is high: the precomputed top 3 Medicare codes account for 71.9% of this provider’s total Medicare revenue, indicating that nearly three-quarters of Medicare earnings are tied to a small set of drug and injection services. This creates operational sensitivity to utilization shifts, drug mix changes, or payer policy adjustments affecting those specific codes.

The provider’s payer mix is effectively single-payer: lifetime Medicare revenue is $1.3M while there is no Medicaid billing on file. The absence of Medicaid activity means little to no Medicaid patient exposure and limited diversification away from Medicare reimbursement.

On competitive standing for major drug codes, CHRIS WU appears to be a modest national participant rather than a market leader: J0178 ranks #1381 of 3204 providers nationally (57th percentile; typical, unremarkable volume), J3490 ranks #988 of 2838 (65th percentile; typical, unremarkable volume), and J2777 ranks #1402 of 2039 (31th percentile; typical, unremarkable volume). These percentiles suggest routine, not outsized, national volumes for the primary revenue-driving medications.

Diagnostic retinal imaging is a relative strength: 92134 shows 1.7K claims and $52.1K revenue (3.9% of Medicare revenue) and ranks #1343 of 26868 providers nationally (95th percentile; notably above typical national volume). High OCT volume supports the clinical model of frequent monitoring and follow-up that complements intravitreal injection services.

Evaluation-and-management coding indicates substantial ambulatory throughput and complexity: 99214 has 568 claims with $59.6K revenue (4.4% of Medicare revenue) and ranks #39274 of 479517 providers nationally (92th percentile; typical, unremarkable volume), while 99204 (new patient) reports 170 claims and $22.1K (1.6%) and ranks in the 97th percentile (notably above typical national volume). This mix points to both a steady base of established-patient follow-ups and a meaningful share of higher-complexity new-patient evaluations.

Operationally notable is J2777’s claim profile: 5.9K claims at $29 avg paid/claim yielding $172.3K revenue (12.8% of Medicare revenue). The combination of very high claim count with low per-claim payment, coupled with a 31th-percentile national rank, suggests frequent, low-unit billing activity for this product relative to peers rather than a small number of high-dollar administrations.

The provider’s tenure and scale are established but moderate: the NPI was enumerated on 2015-04-16 (~11 years ago) and lifetime Medicare revenue totals $1.3M. This tenure supports an experienced, steady practice focused on retinal injections and diagnostics, though overall Medicare revenue places the provider at a modest scale compared with larger retina practices.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

23 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	900	$690	$621K
J3490	Unclassified drugs	80	$2,110	$172.6K
J2777	Injection, faricimab‑svoa, 0.1 mg	5,940	$30	$172.3K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	620	$110	$65.8K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	570	$110	$59.6K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	1,680	$30	$52.1K
J7312	Injection, dexamethasone, intravitreal implant, 0.1 mg	210	$160	$33.4K
J2778	Injection, ranibizumab, 0.1 mg	180	$170	$30.7K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	310	$100	$30.4K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	150	$150	$22.6K

Showing 1–10 of 23

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 23 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Nevada Distribution

Chris Wu — 2 of 23 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Nevada

Full comparison — all codes billed, vs. state median

23 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	12	20	830	$690	$671.6K
J2777	8	10	7,020	$30	$616.8K
J2778	4	10	660	$180	$249.6K
67028	17	30	670	$90	$72.3K
J7312	5	10	380	$160	$68.5K
99214	366	3,610	110	$80	$19K
92014	49	290	90	$80	$15.2K
J3490	14	50	60	$90	$12.7K
99215	143	790	40	$120	$12.2K
92012	47	90	70	$60	$10.6K

Showing 1–10 of 23

Related Providers

Other providers that share a Tax Identification Number (TIN) with Chris Wu, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Nathan Steinle	CA	Retina Specialist (Ophthalmology) Physician	$9.5M	$0
Stephen Couvillion	CA	Retina Specialist (Ophthalmology) Physician	$6.4M	$0
Alessandro Castellarin	CA	Retina Specialist (Ophthalmology) Physician	$5.4M	$0
Dilsher Dhoot	CA	Retina Specialist (Ophthalmology) Physician	$5.4M	$0
Daniel Learned	CA	Retina Specialist (Ophthalmology) Physician	$5.1M	$0
Ash Pirouz	CA	Retina Specialist (Ophthalmology) Physician	$3.1M	$1.3M
William Pace	CA	Nuclear Medicine Physician	$4.1M	$0
Dante Pieramici	CA	Retina Specialist (Ophthalmology) Physician	$3.7M	$0
Daniel Greenwald	CA	Medical Oncology Physician	$3.5M	$0
Ma'an Nasir	CA	Retina Specialist (Ophthalmology) Physician	$3M	$0

Nearby Providers

Other providers in the same ZIP code as Chris Wu, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Sunrise Mountainview Hospital, Inc.	NV	General Acute Care Hospital	$0	$32.1M
Fremont Emergency Services Scherr Ltd	NV	Emergency Medicine Physician	$0	$22.9M
Ellis Bandt Birkin Kollins & Wong PLLC	NV	Diagnostic Radiology Physician	$0	$18.1M
Nevada Acute Medical Services-scherr 1 PC	NV	Hospitalist Physician	$0	$13.5M
Renal Care Group Las Vegas, LLC	NV	End-Stage Renal Disease (ESRD) Treatment Clinic/Center	$0	$13.4M
Laboratory Medicine Consultants Ltd	NV	Clinical Medical Laboratory	$1.9M	$9.2M
Cybt, Inc	NV	In Home Supportive Care Agency	$0	$11.1M
Kan-di-ki LLC	NV	Clinical Medical Laboratory	$5M	$3.6M
Southwest Rehabilitation Physicians & Farhang Associates PLLC	NV	Pain Medicine Physician	$0	$7.1M
New Century Rehabilitation LLC	NV	Physical Therapist	$0	$6.9M

Chris Wu — Billing Profile & Reimbursement Data

Sign up for Chris Wu — Billing Profile & Reimbursement Data policy alerts

Chris Wu — Billing Profile & Reimbursement Data

Sign up for Chris Wu — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References